Setback: Merck-Eisai combination therapy fails in lung cancer studies Ruchika Sharma23 Sept 2023 2:21 PM ISTNew Jersy: Drugmakers Merck and Eisai said on Friday a combination of their cancer therapies did not prolong the lives of patients in two...
Merck gets USFDA priority review for Keytruda plus concurrent chemoradiotherapy for cervical cancer Ruchika Sharma21 Sept 2023 5:33 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
Merck Welireg get USFDA priority review for certain previously treated patients with Advanced Renal Cell Carcinoma Ruchika Sharma21 Sept 2023 2:48 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted and...
Merck gets positive EU CHMP opinion for Keytruda as adjuvant treatment for adults with Non-Small Cell Lung Cancer Ruchika Sharma18 Sept 2023 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...
Merck presents new analyses from Sotatercept studies for adults with pulmonary arterial hypertension Ruchika Sharma13 Sept 2023 1:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced new analyses from studies of sotatercept, Merck’s novel...
Gilead Sciences Trodelvy, Keytruda combo study demonstrates promising clinical activity in first-line Metastatic Non-Small Cell Lung Cancer Ruchika Sharma12 Sept 2023 2:30 PM ISTFoster City: Gilead Sciences, Inc. has announced promising early data from the global, open-label, Phase 2 EVOKE-02 study evaluating Trodelvy...
Merck, Portage Biotech collaborate to evaluate Portage's next-generation adenosine antagonists in combination with Keytruda in solid tumors Ruchika Sharma10 Sept 2023 11:30 AM ISTWestport: Portage Biotech Inc., a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in...
European Commission expands Merck Ervebo indication to include children 1 year of age and older Ruchika Sharma9 Sept 2023 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Commission (EC) has approved an expanded...
Merck, Eisai to shut down late stage study for combo cancer therapy Ruchika Sharma28 Aug 2023 12:31 PM ISTThe companies are testing the combination to treat a range of cancers, including those affecting the lungs and stomach.
Merck declares topline results from Phase 3 trial of Welirag Ruchika Sharma19 Aug 2023 4:04 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced topline results from LITESPARK-005, the first positive Phase 3...
Ginkgo Bioworks, Merck collaborate to improve biologic manufacturing Ruchika Sharma10 Aug 2023 3:30 PM ISTBoston: Ginkgo Bioworks, which is building the platform for cell programming and biosecurity, has announced a new collaboration with Merck, known...
Merck KGaA flags steeper profit drop on lower orders from drugmakers Ruchika Sharma6 Aug 2023 12:00 PM ISTFrankfurt: Germany's Merck KGaA on Thursday warned of a steeper earnings decline due to a slump in demand for materials used to produce...
